The Greenshoe Option: The Bank That Shorts the Stock It Just Sold

You've probably heard of an airline selling more tickets than seats on the plane, betting on a predictable number of no-shows to make the arithmetic work out even.

An IPO underwriter does something that looks similar and works in reverse. It sells more shares of a newly public company than the deal was actually sized for — up to 15% more — without knowing in advance whether it will cover that excess by finding extra "seats" (fresh shares from the company) or by buying "tickets" back from people who no longer want theirs (shares bought back in the open market). Which one happens depends entirely on what the stock does in its first month of trading.

That mechanism has a name that gives away nothing about what it does: the greenshoe option. It's named after Green Shoe Manufacturing Company, a Boston shoemaker — later renamed Stride Rite — whose underwriters, during its 1963 listing on the New York Stock Exchange, were the first to write this exact clause into an underwriting agreement. The company made shoes. The clause it accidentally lent its name to now runs on nearly every large IPO in the world, including ones that have never made a single shoe.

What the greenshoe option actually is

In India, the mechanism runs as the Green Shoe Option, governed by Regulation 57 of SEBI's ICDR Regulations, available to Indian IPOs since 2003. A merchant banker appointed as the issue's Stabilising Agent borrows up to 15% of the issue size in shares from the company's promoters before the IPO and sells them alongside the regular allotment — a short position, taken on purpose, with the promoters' and the regulator's explicit sign-off. What happens next, over a stabilisation window running up to 30 days, depends entirely on where the stock trades.

If the price falls below the issue price, the Stabilising Agent buys shares in the open market to cover that short and return what was borrowed. This does two things at once: it closes out the short position, and the buying itself pushes back against the very weakness that triggered it — real demand, arriving exactly when the stock needs it most.

If the price holds above the issue price, the Stabilising Agent doesn't need to prop anything up. Instead, it subscribes to fresh shares from the company at the original issue price — literally exercising an option, a genuine call — and returns those to the promoters to settle the borrow. The company issues the shares, collects the cash, and the short position closes without a single trade hitting the open market.

Either way, the short gets covered. The only question the market itself answers is how.

The US runs the identical mechanic under the name that gave the whole thing its name: the classic over-allotment option, sized the same way — up to 15% of the deal — and settled the same two ways, either bought back in the open market to support a falling price or exercised as an option to buy the extra shares straight from the issuer. Same 15% cap. Same logic on both sides of the trade. Only the paperwork and the name on the regulation differ.

Why markets needed this

An IPO's underwriter has one job that outlasts the day of listing: making sure the first month of trading doesn't turn into a rout. A stock that opens weak and keeps sliding doesn't just cost early investors money — it poisons the market's appetite for every IPO that comes after it, in a way no single company's fundamentals can fix on their own. The greenshoe exists because the underwriter, not just the company, has skin in that outcome.

India's IPO market spent 2023 and 2024 defying almost everything happening to IPO markets elsewhere. Indian exchanges became the world's busiest by number of listings in 2023, and 2024 went further still — a record 268 IPOs on the NSE alone, raising roughly ₹1.67 lakh crore, more capital raised in the primary market than any other exchange globally that year. Deep, steady domestic retail and institutional demand kept absorbing new listings in India even as foreign capital turned cautious everywhere. A greenshoe matters just as much in a market that's thriving as one that's struggling — new listings in India's boom years still needed thirty days of price support like any other IPO does — and the sheer volume of deals meant India's stabilising agents were running this exact mechanism more often, on more listings, than almost anywhere else in the world.

They were running it against a starkly different backdrop everywhere else. Rising interest rates and a collapse in risk appetite took the global IPO market from a record 2021 to a 61% fall in proceeds the very next year; by early 2023, quarterly IPO proceeds worldwide were still down more than 65% year-on-year, and software IPO proceeds alone fell from $120 billion to $10 billion in a single year. Underwriters elsewhere spent 2022 and 2023 leaning on stabilisation mechanisms like the greenshoe far harder than usual, on a much smaller number of deals, because nearly every listing that did make it out the door was doing so into a market with almost no room for error. Same tool, same 30-day window — one market needed it to survive a drought, the other needed it to keep pace with a boom.

Why this matters for a Business Analyst

Think of an airline's seating chart the moment boarding closes

The moment an overbooked flight finishes boarding, the airline's own seating chart can't yet say how many seats are actually filled — that depends on how many no-shows turn up, a fact that won't be settled until the gate physically closes.

"The company has X shares outstanding as of the IPO date."

For up to 30 days after a listing that used a greenshoe, that sentence is the seating chart before the gate closes. The true share count is genuinely undetermined — not unknown due to a data lag, but unresolved as a matter of fact — because it depends on whether the stabilising agent ends up exercising the option (issuing new shares, diluting existing holders) or buying back in the market (issuing nothing, no dilution at all). A cap table or shares-outstanding field that gets hard-coded on listing day and never revisited is recording a number that hasn't actually happened yet as if it already had.

An Indian company that lists on the NSE with a SEBI Reg 57 greenshoe carries that exact ambiguity for 30 days after allotment — its true post-IPO share count hinges on whether the Stabilising Agent ends up buying in the market or subscribing to fresh shares, a fact settled by trading, not by the prospectus. A US company listing on Nasdaq with the classic over-allotment option carries the identical ambiguity for the identical reason, just under a different regulation's name.

Get that distinction wrong in a system on either exchange, and every downstream calculation that depends on share count — earnings per share, ownership percentage, market capitalisation — is built on a number that was still contingent on thirty days of market behaviour nobody could see coming on day one.

Lighthouse Insight

Go back to the shoe company nobody remembers for making shoes.

Green Shoe Manufacturing didn't invent a financial instrument on purpose. Its underwriters wrote one clause into one contract in 1963, trying to solve one company's very ordinary listing-day problem — and the clause outlived the company's own name.

A greenshoe doesn't guarantee an IPO succeeds. It just makes sure that if the market gets nervous in the first month, someone with real capital and a real reason to care is standing there ready to buy — not because they believe in the stock, but because covering a short they created on purpose was always part of the deal.